Patient safety is the primary objective of infection prevention but infection preventionists in a Syracuse healthcare system demonstrate how to make the business case for investing in protocols that save both money and lives, according to intervention outcomes presented at the 46th Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC) last week in Philadelphia.
Results of a two-year update of the world's first comparative trial of mass drug administration against scabies, show that the infection rate is still significantly down. The latest findings are published today in the New England Journal of Medicine.
Researchers who analyzed data in the electronic health records (EHR) of children seen by hematology/oncology specialists at three large medical centers have developed an algorithm to accurately identify appropriate pediatric oncology patients for future clinical studies. By expediting and refining the selection of patients for research, the researchers aim to ultimately improve outcomes for a variety of pediatric cancers.
Increased glucose, transformed into energy, could give people with amyotrophic lateral sclerosis, or ALS, improved mobility and a longer life, according to new findings by a University of Arizona-led research team.
Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialised countries. In 2015 alone, 250,000 people in the UK were diagnosed with IBD, and 3 million in the United States (1, 2). Symptoms can include pain and swelling of the stomach, bloody diarrhoea, weight loss and extreme tiredness.
Therapies to improve recovery after a heart attack could be developed following fresh insights into how key cells are formed.
A risk prediction model developed using clinical and radiological features could stratify individuals presenting with a lung nodule as having high or low risk for lung cancer.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου